Eleven Bio Inc (EBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | EBIO | CRDF | BCAB | ||
Company | Eleven Bio Inc | Cardiff Oncology Inc | Bioatla Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.74 | 3.98 | 3.23 | ||
High | 3.44 | 4.42 | 3.33 | ||
Low | 2.73 | 3.12 | 3.10 | ||
Last | 3.29 | 3.52 | 3.25 | ||
Change | +0.64 | -0.96 | +0.09 | ||
% Change | +24.15% | -21.43% | +2.85% | ||
Volume | 15,611,300 | 2,160,600 | 452,600 | ||
20-Day Average Volume | 7,990,690 | 835,705 | 727,965 | ||
Previous Close | 2.65 | 4.48 | 3.16 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.65 | 4.68 | 2.79 | ||
20-Day Raw Stochastic | 89.39% | 12.70% | 63.36% | ||
20-Day Relative Strength | 69.62% | 40.54% | 56.04% | ||
Weighted Alpha | +35.90 | +18.24 | -25.67 | ||
Today's Opinion | N/A | 56% Buy | 80% Buy | ||
Previous Opinion | N/A | 72% Buy | 96% Buy | ||
Last Month's Opinion | N/A | 100% Buy | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +16.25% since 05/09/18 | -13.51% since 04/26/24 | +27.95% since 04/26/24 | ||
Low | 2.56 on 05/11/18 | 3.12 on 05/03/24 | 2.21 on 04/30/24 | ||
High | 3.44 on 05/16/18 | 4.68 on 04/29/24 | 3.53 on 05/01/24 | ||
1-Month | |||||
%Chg | +108.23% since 04/16/18 | -33.96% since 04/03/24 | -12.16% since 04/03/24 | ||
Low | 1.42 on 04/18/18 | 3.12 on 05/03/24 | 2.01 on 04/22/24 | ||
High | 3.50 on 05/02/18 | 6.38 on 04/04/24 | 4.02 on 04/04/24 | ||
3-Month | |||||
%Chg | +255.68% since 02/16/18 | +121.38% since 02/02/24 | +51.16% since 02/02/24 | ||
Low | 0.90 on 03/02/18 | 1.44 on 02/05/24 | 2.01 on 04/22/24 | ||
High | 3.50 on 05/02/18 | 6.42 on 03/25/24 | 4.02 on 04/04/24 | ||
6-Month | |||||
%Chg | +391.04% since 11/16/17 | +217.12% since 11/03/23 | +75.68% since 11/03/23 | ||
Low | 0.63 on 12/07/17 | 0.94 on 11/10/23 | 1.35 on 12/04/23 | ||
High | 3.50 on 05/02/18 | 6.42 on 03/25/24 | 4.02 on 04/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 157,229 | 157,379 | 156,315 | ||
Shares Outstanding, K | 47,790 | 44,710 | 48,097 | ||
Annual Sales | 430,000 | 490,000 | 0 | ||
Annual Net Income | -29,030,000 | -41,440,000 | -123,460,000 | ||
Last Quarter Sales | N/A | 160,000 | 0 | ||
Last Quarter Net Income | N/A | -9,340,000 | -26,930,000 | ||
60-Month Beta | 2.75 | 2.02 | 1.23 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.21 on 02/29/24 | -0.56 on 03/26/24 | ||
Latest Earnings Date | 05/17/18 | 05/02/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |